- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Aptorum Group Ltd Class A is a biotechnology business based in the US. Aptorum Group Ltd Class A shares (APM) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.74 – a decrease of 3.5% over the previous week. Aptorum Group Ltd Class A employs 3 staff and has a trailing 12-month revenue of around $431,378.
What's in this guide?
Our top picks for where to buy Aptorum Group Ltd Class A stock
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options with no options contract fees
- Get up to $1,000 in stock when you fund a new account within 30 days
- Complimentary access to a financial planner
Probability of member receiving $1,000 is 0.028%
How to buy Aptorum Group Ltd Class A stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – APM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Aptorum Group Ltd Class A stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
What is the Finder Score?
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Aptorum Group Ltd Class A stock price (NASDAQ: APM)
Use our graph to track the performance of APM stocks over time.Aptorum Group Ltd Class A shares at a glance
Information last updated 2024-12-18.
| Latest market close | $0.74 |
|---|---|
| 52-week range | $0.46 - $11.95 |
| 50-day moving average | $1.17 |
| 200-day moving average | $3.78 |
| Wall St. target price | $80.00 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-0.62 |
Is it a good time to buy Aptorum Group Ltd Class A stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Aptorum Group Ltd Class A price performance over time
Historical closes compared with the close of $0.7399 from 2024-12-20
| 1 week (2024-12-13) | -3.50% |
|---|---|
| 1 month (2024-11-22) | -0.01% |
| 3 months (2024-09-20) | -65.98% |
| 6 months (2024-06-21) | -83.81% |
| 1 year (2023-12-21) | -66.21% |
|---|---|
| 2 years (2022-12-21) | -86.54% |
| 3 years (2021-12-21) | 17.3 |
| 5 years (2019-12-20) | 142.5 |
Aptorum Group Ltd Class A financials
| Revenue TTM | $431,378 |
|---|---|
| Gross profit TTM | $81,854 |
| Return on assets TTM | -32.3% |
| Return on equity TTM | -37.4% |
| Profit margin | 0% |
| Book value | $4.80 |
| Market Capitalization | $4.2 million |
TTM: trailing 12 months
Aptorum Group Ltd Class A share dividends
We're not expecting Aptorum Group Ltd Class A to pay a dividend over the next 12 months.
Have Aptorum Group Ltd Class A's shares ever split?
Aptorum Group Ltd Class A's shares were split on a 1:10 basis on 22 January 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aptorum Group Ltd Class A shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aptorum Group Ltd Class A shares which in turn could have impacted Aptorum Group Ltd Class A's share price.
Aptorum Group Ltd Class A share price volatility
Over the last 12 months, Aptorum Group Ltd Class A's shares have ranged in value from as little as $0.46 up to $11.95. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aptorum Group Ltd Class A's is 1.3. This would suggest that Aptorum Group Ltd Class A's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Aptorum Group Ltd Class A overview
Aptorum Group Limited, through its subsidiaries, operates as a clinical stage biopharmaceutical company that engages in the discovery, development, and commercialization of therapeutic products for the treatment of oncology and infectious diseases. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; ALS-1 to treat viral infections caused by influenza virus A; and ALS-2/3 for the treatment of gram+ve bacterial infections. The company is also developing RPIDD, a pathogen molecular diagnostic; NativusWell DOI (NLS-2), a dietary supplement; NLS-1 for the treatment of endometriosis; DLS-1+2 to treat NSCLC with mutation; DLS-3, an autoimmune small molecule; and CLS-1 for the treatment of obesity. Its pipeline products enable the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platforms for treatment of metabolic diseases. The company also focuses on therapeutic and diagnostic projects in neurology, gastroenterology, metabolic disorders, and other disease areas. In addition, it is involved in the operation of medical clinics.
Frequently asked questions
nullWhat percentage of Aptorum Group Ltd Class A is owned by insiders or institutions?
Currently 23.713% of Aptorum Group Ltd Class A shares are held by insiders and 1.459% by institutions. How many people work for Aptorum Group Ltd Class A?
Latest data suggests 3 work at Aptorum Group Ltd Class A. When does the fiscal year end for Aptorum Group Ltd Class A?
Aptorum Group Ltd Class A's fiscal year ends in December. Where is Aptorum Group Ltd Class A based?
Aptorum Group Ltd Class A's address is: 17 Hanover Square, London, United Kingdom, W1S 1BN What is Aptorum Group Ltd Class A's ISIN number?
Aptorum Group Ltd Class A's international securities identification number is: KYG6096M1069 What is Aptorum Group Ltd Class A's CUSIP number?
Aptorum Group Ltd Class A's Committee on Uniform Securities Identification Procedures number is: G6096M106
More resources on Finder
More guides on Finder
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
Sweep Accounts
Check out our picks for the brokers with the best cash sweep rates on uninvested cash.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
5 best stock picking services of 2024
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
-
5 Top Graphene Stocks to Invest in Today
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Ratings methodology for online brokers
Our star ratings for online brokerages are based on how they stack up in nine key categories.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to Invest $10K
Maximize $10,000 with broker bonuses, IRA contribution matches, index funds, stocks, ladder CDs, hiring a financial advisor and more.
-
5 best ETFs for 2024
Check out the best-performing ETFs so far in 2024.
Ask a question